Table 3.
Comparisons by mean difference of serum copper and zinc levels, for the intervention and control groups, on days 1 and 21 of the clinical trial.
| Variable | Comparisons | Mean difference | p-value | CI 95 % LL | CI 95 % UL |
|---|---|---|---|---|---|
| Copper | A – B (D1) | −45,6 | 0,47 | −171.4 | 80,1 |
| A – B (D21) | −67,7 | 0,28 | −193.5 | 58,1 | |
| D1 - D21 (A) | 78,0 | 0,11 | −19.1 | 175,1 | |
| D1 - D21 (B) | 55,9 | 0,25 | −41.2 | 153,1 | |
| Zinc | A – B (D1) | −33,5 | 0,57 | −150.8 | 83,8 |
| A – B (D21) | 58,2 | 0,32 | −59.1 | 175,6 | |
| D1 - D21 (A) | 149,5 | <0,01 | 67.0 | 231,9 | |
| D1 - D21 (B) | 241,2 | <0,01 | 158.7 | 323,7 |
D1, first day of the study; D2, twenty-first day of the study; Lioneo group (A), newborns who received human milk with a human milk-based additive; HMCA group (B), newborns who received human milk with a cow milk protein-based additive; 95 % CI, 95 % confidence interval; LL, lower limit; UL, upper limit.